fotemustine
Term · Oncology and biomedicine · MLC-T-ONC-003331
A substance being studied in the treatment of advanced melanoma, glioblastoma (a type of brain tumor) that has come back, and certain types of lymphoma. Fotemustine damages the cell’s DNA and may kill cancer cells. It is a type of alkylating agent and a type of nitrosourea.
A chloroethylating nitrosourea with antineoplastic activity. Fotemustine alkylates guanine by forming chloroethyl adducts at the 6 position of guanine, resulting in N1-guanine and N3-cytosine cross linkages, inhibition of DNA synthesis, cell cycle arrest, and finally apoptosis. This agent is lipophilic and crosses the blood-brain barrier.
| Identifier | MLC-T-ONC-003331 |
|---|---|
| Field | Oncology and biomedicine |
| References | NCI Dictionary of Cancer Terms; National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-003331",
"term": "fotemustine",
"field": "Oncology and biomedicine",
"definitions": [
"A substance being studied in the treatment of advanced melanoma, glioblastoma (a type of brain tumor) that has come back, and certain types of lymphoma. Fotemustine damages the cell’s DNA and may kill cancer cells. It is a type of alkylating agent and a type of nitrosourea.",
"A chloroethylating nitrosourea with antineoplastic activity. Fotemustine alkylates guanine by forming chloroethyl adducts at the 6 position of guanine, resulting in N1-guanine and N3-cytosine cross linkages, inhibition of DNA synthesis, cell cycle arrest, and finally apoptosis. This agent is lipophilic and crosses the blood-brain barrier."
],
"references": [
"NCI Dictionary of Cancer Terms",
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/fotemustine/"
}
Record 7,592 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.